Literature DB >> 32274396

Dysregulated KDR and FLT1 Gene Expression in Colorectal Cancer Patients.

Fatemeh Mohammad Rezaei1,2, Shahryar Hashemzadeh2,3, Reyhaneh Ravanbakhsh Gavgani4, Mohammadali Hosseinpour Feizi5, Nasser Pouladi6, Hossein Samadi Kafil7, Leila Rostamizadeh1, Vahid Kholghi Oskooei8, Mohammad Taheri9, Ebrahim Sakhinia10.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is one of the most commonly-diagnosed malignancies throughout the world and the fourth-leading cause of cancer deaths globally. Angiogenesis and the resultant tumor neovascularization is a well-known cancer hallmark. Here we investigated the expression of FLT1 and KDR, the influential genes in angiogenesis regulation, in CRC patients.
METHODS: We assessed FLT1 and KDR mRNA expression in 47 CRC samples and matched adjacent noncancerous tissues (ANCT) by quantitative real-time PCR. The Spearmen correlation coefficient and receiver operating characteristic (ROC) curves were also examined.
RESULTS: Both genes were expressed at significantly greater levels in CRC tissues than in ANCT (p < 0.05). A significant association was found between KDR expression and disease stage and lymph status in CRC patients. Furthermore, the Spearman correlation demonstrated a moderate correlation between FLT1 and KDR expression in CRC samples. Finally, ROC curve analysis demonstrated that FLT1 had the greatest sensitivity (85.1%), while the greatest specificity was achieved by a combination of the two genes.
CONCLUSION: The dysregulated FLT1 and KDR expression, in addition to the observed correlation and ROC curve results, indicate the critical importance of angiogenesis among the cancer pathways in CRC. These data can broaden our current knowledge of angiogenesis in CRC to improve disease diagnosis and patient treatment.

Entities:  

Keywords:  Colorectal cancer; FLT1; Gene expression; KDR

Year:  2019        PMID: 32274396      PMCID: PMC7103086     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  26 in total

1.  Expression analysis of vitamin D receptor-associated lncRNAs in epileptic patients.

Authors:  Mehrdokht Mazdeh; Mehrdad Zamani; Mohammad Mahdi Eftekharian; Alireza Komaki; Shahram Arsang-Jang; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2019-06-11       Impact factor: 3.584

2.  Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer.

Authors:  Guanglong Dong; Xu Guo; Xiaoying Fu; Shaogui Wan; Feng Zhou; Ronald E Myers; Guoqiang Bao; Ashlie Burkart; Hushan Yang; Jinliang Xing
Journal:  Cancer Sci       Date:  2012-01-16       Impact factor: 6.716

3.  Immunohistochemical Expression of Fatty Acid Synthase and Vascular Endothelial Growth Factor in Primary Colorectal Cancer: a Clinicopathological Study.

Authors:  Asmaa Hussein Mohamed; Nelly Mohamed Said
Journal:  J Gastrointest Cancer       Date:  2019-09

Review 4.  Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.

Authors:  Mohammad Mashreghi; Hassan Azarpara; Mahere R Bazaz; Arash Jafari; Aria Masoudifar; Hamed Mirzaei; Mahmoud R Jaafari
Journal:  J Cell Physiol       Date:  2017-08-03       Impact factor: 6.384

5.  Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.

Authors:  Eun-Kee Song; W M Tai; Wells A Messersmith; Stacey Bagby; Alicia Purkey; Kevin S Quackenbush; Todd M Pitts; Guoliang Wang; Patrick Blatchford; Rachel Yahn; Jeffrey Kaplan; Aik Choon Tan; Chloe E Atreya; Gail Eckhardt; Robin K Kelley; Alan Venook; Eunice L Kwak; David Ryan; John J Arcaroli
Journal:  Int J Cancer       Date:  2014-09-29       Impact factor: 7.396

6.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

7.  Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells.

Authors:  Araceli Valverde; Jon Peñarando; Amanda Cañas; Laura M López-Sánchez; Francisco Conde; Vanessa Hernández; Esther Peralbo; Chary López-Pedrera; Juan de la Haba-Rodríguez; Enrique Aranda; Antonio Rodríguez-Ariza
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

8.  Assessing tumor angiogenesis in colorectal cancer by quantitative contrast-enhanced endoscopic ultrasound and molecular and immunohistochemical analysis.

Authors:  Elena-Tatiana Cartana; Dan Ionuţ Gheonea; Irina Florina Cherciu; Ioana Streaţa; Constantin-Daniel Uscatu; Elena-Raluca Nicoli; Mihai Ioana; Daniel Pirici; Claudia-Valentina Georgescu; Dragoş-Ovidiu Alexandru; Valeriu Şurlin; Gabriel Gruionu; Adrian Săftoiu
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

9.  Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.

Authors:  Jihyoun Jeon; Mengmeng Du; Robert E Schoen; Michael Hoffmeister; Polly A Newcomb; Sonja I Berndt; Bette Caan; Peter T Campbell; Andrew T Chan; Jenny Chang-Claude; Graham G Giles; Jian Gong; Tabitha A Harrison; Jeroen R Huyghe; Eric J Jacobs; Li Li; Yi Lin; Loïc Le Marchand; John D Potter; Conghui Qu; Stephanie A Bien; Niha Zubair; Robert J Macinnis; Daniel D Buchanan; John L Hopper; Yin Cao; Reiko Nishihara; Gad Rennert; Martha L Slattery; Duncan C Thomas; Michael O Woods; Ross L Prentice; Stephen B Gruber; Yingye Zheng; Hermann Brenner; Richard B Hayes; Emily White; Ulrike Peters; Li Hsu
Journal:  Gastroenterology       Date:  2018-02-17       Impact factor: 33.883

10.  KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer.

Authors:  Arturo Loaiza-Bonilla; Christopher E Jensen; Stuti Shroff; Emma Furth; Paula A Bonilla-Reyes; Andres F Deik; Jennifer Morrissette
Journal:  Cureus       Date:  2016-02-03
View more
  5 in total

1.  Identification of Genomic Alterations of Perineural Invasion in Patients with Stage II Colorectal Cancer.

Authors:  Hao Su; Chen Chang; Jiajie Hao; Xin Xu; Mandula Bao; Shou Luo; Chuanduo Zhao; Qian Liu; Xishan Wang; Zhixiang Zhou; Haitao Zhou
Journal:  Onco Targets Ther       Date:  2020-11-11       Impact factor: 4.147

2.  Pyrethroid-linked resistance allelic mutations by molecular analysis in wild human head louse (Phthiraptera: Pediculidae) populations from schoolgirls of South Iran.

Authors:  J Mohammadi; H Alipour; K Azizi; M Shahriari-Namadi; M Kalantari; S Ebrahimi; M D Moemenbellah-Fard
Journal:  Parasite Epidemiol Control       Date:  2022-05-02

3.  Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells.

Authors:  Stephanie A Sheehan; Edward P Retzbach; Yongquan Shen; Harini Krishnan; Gary S Goldberg
Journal:  Cell Commun Signal       Date:  2022-02-17       Impact factor: 5.712

4.  Modular and mechanistic changes across stages of colorectal cancer.

Authors:  Sara Rahiminejad; Mano R Maurya; Kavitha Mukund; Shankar Subramaniam
Journal:  BMC Cancer       Date:  2022-04-21       Impact factor: 4.638

5.  MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.

Authors:  Bin Yang; Huijuan Liu; Yanghui Bi; Caixia Cheng; Guodong Li; Pengzhou Kong; Ling Zhang; Ruyi Shi; Yunkui Zhang; Rongsheng Zhang; Xiaolong Cheng
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.